Product description
KLOW combines GHK-Cu, BPC-157, a thymosin beta-4 fragment, and KPV in one lyophilized research formulation. The blend is intended for qualified laboratories evaluating multi-compound interactions across cellular, extracellular-matrix, and inflammatory-signaling models.
The specification record provides the identity, supplied format, available quantities, and storage information needed for procurement review and sample tracking. Researchers are responsible for establishing preparation, concentration, controls, and stability procedures appropriate to their validated methods.
